Urinary Incontinence, Urge clinical trials
The registry lists 242 studies for Urinary Incontinence, Urge across more than 10 countries. 38 are recruiting or about to start. 98 of them are mainly about Urinary Incontinence, Urge (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.
Get an email when these change. Save the Urinary Incontinence, Urge studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Astellas Pharma Inc (6) · MedtronicNeuro (6) · Axonics, Inc. (6) · University of California, San Francisco (6) · Valencia Technologies Corporation (4) · InnoCon Medical (4) · University of New Mexico (4) · Urovant Sciences GmbH (4)
What is being tested here
Drugs under test in Urinary Incontinence, Urge studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Botulinum toxin type A | 1 | 5 | 11 |
| Mirabegron | 1 | 5 | 9 |
| Lidocaine | 1 | 1 | 5 |
| Tolterodine | 1 | 1 | 5 |
| Tadalafil | 1 | 0 | 2 |
| Onabotulinum toxin A | 1 | 1 | 2 |
| Nitrous Oxide | 1 | 0 | 1 |
| Oxygen | 1 | 0 | 1 |
| Cholecalciferol | 1 | 0 | 1 |
| Solifenacin | 0 | 0 | 5 |
Drug classes tested here Antimuscarinics 1 open · Beta-3 agonists 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women · Medstar Health Research Institute
- Nov 2026A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections · TriHealth Inc.
- Nov 2026Aquarius Pilot Study to Evaluate the New Axonics Trial System · Axonics, Inc.
- Nov 2026Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System · Neuspera Medical, Inc.
- Nov 2026Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence · Fundación Universidad Católica de Valencia San Vicente Mártir
- Nov 2026Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder · IRCCS San Raffaele
- Nov 2026Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public Hospital · Hospital Nacional Edgardo Rebagliati Martins
- Dec 2026F15 Recharge Free Axonics SNM System Clinical Study · Axonics, Inc.
- Dec 2026Percutaneous Nerve Evaluation Trial Time · University of Chicago
- Jan 2027PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB · Axonics, Inc.
Who these studies take
Of the 25 Urinary Incontinence, Urge studies recruiting now, 18 (72%) set no upper age limit and 2 (8%) stop at 75 or younger. 1 (4%) take children under 18. 13 (52%) are for women only and 2 (8%) for men only; 2 (8%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (4%) | 1 (4%) |
| 18 | 13 (52%) | 9 (36%) |
| 30 | 18 (72%) | 10 (40%) |
| 40 | 18 (72%) | 10 (40%) |
| 50 | 19 (76%) | 10 (40%) |
| 65 | 22 (88%) | 11 (44%) |
| 75 | 22 (88%) | 11 (44%) |
| 85 | 18 (72%) | 11 (44%) |
Across all 242 studies, recruiting or not: 13% stop at 75 or younger and 8% at 65; 4% take children; 64% are for women only and 3% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Urinary Incontinence, Urge studies take
Of 11 phase 3 interventional studies under Urinary Incontinence, Urge, half reached primary completion within 12 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 3 | 12 mo10–24 · 11 studies | — | — |
| Interventional, no phase | 20 mo10–41 · 77 studies | — | 23 mo11–43 · 47 studies |
| Observational | 34 mo18–45 · 19 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 242. Browse all 242 → or search them.
- Aquarius Pilot Study to Evaluate the New Axonics Trial SystemRecruitingNCT07335484Not applicable2 countries
- Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate CancerRecruitingNCT06161506Phase 21 country
- Safety and Performance of UCon Patch ElectrodeRecruitingNCT06754189Not applicable1 country
- UCon Treatment of Overactive Bladder (OAB) in MalesRecruitingNCT05874375Not applicable1 country
- Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial DeviceRecruitingNCT07456865Not applicable1 country
- A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)RecruitingNCT05685433Not applicable1 country
- Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes MetricsRecruitingNCT073836881 country
- Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve StimulationNot yet recruitingNCT07744620Not applicable1 country
- Urinary Continence After Vaginal Surgery for Genital Prolapse in the Spanish Population.Not yet recruitingNCT076280361 country
- Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)RecruitingNCT06885931Not applicable3 countries
- COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCENot yet recruitingNCT07536139Not applicable1 country
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetRecruitingNCT06201013Not applicable1 country
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruitingNCT07473310Phase 41 country
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruitingNCT04527445Not applicable1 country
- TReating Incontinence for Underlying Mental and Physical HealthRecruitingNCT05362292Phase 41 country
- Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) SystemRecruitingNCT07247136Not applicable1 country
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National StudyRecruitingNCT07416968Phase 41 country
- Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)RecruitingNCT06091566Not applicable1 country
- Percutaneous Nerve Evaluation Trial TimeRecruitingNCT06226220Not applicable1 country
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox InjectionsNot yet recruitingNCT07387315Phase 41 country
- Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in WomenRecruitingNCT07209397Not applicable1 country
- Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive BladderNot yet recruitingNCT07279142Not applicable1 country
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss TherapyNot yet recruitingNCT071758051 country
- Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor InjectionsRecruitingNCT070250441 country
- Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive BladderRecruitingNCT05997992Not applicable1 country
- Effect of Neuromodulation and Therapeutic Exercise in Urinary IncontinenceRecruitingNCT06783374Not applicable1 country
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a InjectionsNot yet recruitingNCT06695585Phase 41 country
- Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal WomenNot yet recruitingNCT06617676Not applicable
- Optimal Injection Interval for Intra-Detrusor Botulinum ToxinNot yet recruitingNCT06483217Not applicable1 country
- Real-World Registry - The Vivally® SystemEnrolling by invitationNCT060858461 country
- Prevalence, Types and Risk Factors of Urinary Incontinence Among Women in Baghdad, Iraq.RecruitingNCT063528791 country
- Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older PeopleRecruitingNCT040947531 country
- Effect of Mobile Application on Urinary IncontinenceEnrolling by invitationNCT05404386Not applicable1 country
- Urinary Stress Incontinence and Urgency in Women With EMSELLARecruitingNCT03877640Not applicable1 country
- CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation TechnologyRecruitingNCT02577302Not applicable1 country
- To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary IncontinenceNot yet recruitingNCT05948397
- The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and LonelinessNot yet recruitingNCT05892575Not applicable1 country
- Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin ARecruitingNCT04305743Phase 41 country
- F15 Recharge Free Axonics SNM System Clinical StudyActive, not recruitingNCT06186765Not applicable3 countries
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABActive, not recruitingNCT06789406Not applicable2 countries
- High Intensity Magnetic Stimulation on Urge Urinary Incontinence in Postmenopausal WomenCompletedNCT07731711Not applicable1 country
- Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized TrialCompletedNCT07184307Not applicable1 country
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenActive, not recruitingNCT06797245Not applicable1 country
- INTIBIA Pivotal StudyActive, not recruitingNCT05250908Not applicable2 countries
- Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)Active, not recruitingNCT05375344Not applicable1 country
- Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public HospitalActive, not recruitingNCT07858968Not applicable1 country
- INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive BladderWithdrawnNCT05309993Not applicable1 country
- Long-term Outcomes of Urethral and Uterosacral Ligament PlicationCompletedNCT07384117Not applicable1 country
- NXT Post-Market Clinical Follow-upTerminatedNCT063363041 country
- Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary IncontinenceCompletedNCT07151170Not applicable1 country